- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02834156
Impact of Child Positioning on Pain During a Lumbar Puncture (PHIPA-PEPL)
Impact Assessment of Positioning on Pain Sensitivity During a Lumbar Puncture in Children
This protocol is a pilot study on standard care. The main goal is to assess the impact of positioning on lumbar puncture process especially on pain sensitivity in children.
It's a prospective, monocentric, randomized, open-label, cross-over study. Inclusion period is one year, and number of inclusions forecasted is about 30. Each patient will have one LP in a seated position and one in a lying position.
Study Overview
Status
Conditions
Detailed Description
In Pediatric Oncology Hematology, invasive procedures such lumbar punctures or myelograms are essential to diseases diagnosis and treatment.
In hematological malignancies, lumbar punctures are particularly frequent as the therapy processes. Despite a good analgesia, this repeated procedure can generate pain, anxiety, apprehension leading to an increasing difficulty in the procedure realization.
Two positions are possible to carry out lumbar puncture: seated or lying position.
The main goal of this study is to assess the impact of the child positioning during the lumbar puncture process in term of pain, anxiety and stress.
This study is a prospective, monocentric, randomized, open-label, cross-over study. Inclusion period is 1 year, 30 patients will be included from 2 to 18 years old.
Each patient will have 2 LP one in seated and one in lying position in a specific order determined by randomization.
All data regarding pain and anxiety will be collected the day of LP. Patients will be re contacted 48 hours and 15 days after LP procedure in order to evaluate complications such post-lumbar puncture syndrome or hematoma. The main analysis will be done on intent-to-treat-analysis basis and will compare pain intensity between the two groups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nice, France, 06000
- CHU de Nice
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 2 and 18 years old
- Patients requiring at least 2 therapeutic lumbar punctures
- Patients able to receive analgesic procedure according to 20005 good practices recommendation
- Presence of one parent during LP procedure
- Child able to use assessment scales
- LP realized with a 20 G needle
- Platelets > 50000
- Child with prior clinical examination
- Affiliated to a health care insurance regimen
Exclusion Criteria:
- Seated or lying position impossible
- Lumbar puncture contraindication
- Patient or parent opposition to second LP realization in the required position
- Clotting trouble on LP day not allowing the LP procedure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: LP in a seated position then LP in a lying position
Patients will have first a lumbar puncture (LP) in a seated position then a LP in a lying position
|
|
|
Other: LP in a lying position then LP in a seated position
Patients will have first a lumbar puncture (LP) in a lying position then a LP in a seated position
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain sensitivity during the lumbar puncture procedure.
Time Frame: duration of the procedure
|
It will be evaluated throw specific pain assessment scales according to patient age
|
duration of the procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Anxiety during the lumbar puncture procedure on a scale of one to ten
Time Frame: duration of the procedure
|
duration of the procedure
|
|
Time of the lumbar puncture procedure
Time Frame: duration of the procedure
|
duration of the procedure
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-PP-05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hematological Malignancies
-
Donghua ZhangNot yet recruitingCD7-Positive Hematological MalignanciesChina
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection BiologyUnknownPediatric Solid Malignancies | Pediatric Hematological MalignanciesIsrael
-
AdaptimmuneTerminatedSolid and Hematological MalignanciesUnited States, Canada
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Centre Hospitalier Universitaire de BesançonTerminatedHematological Malignancies BFrance
-
CASI Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hematological MalignanciesCanada
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory Hematological MalignanciesChina
-
AdaptimmuneCompletedSolid and Hematological MalignanciesUnited States, Canada, Spain, United Kingdom
-
AstraZenecaParexelCompletedSolid and Hematological MalignanciesGermany
-
Shanghai Chia Tai Tianqing Pharmaceutical Technology...Not yet recruitingPhase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological MalignanciesCD20-positive Hematological MalignanciesChina
Clinical Trials on LP in a seated position then LP in a lying position
-
Anna OlczakCompleted
-
A.T. Still University of Health SciencesCompletedNeck PainUnited States
-
European University of LefkeCompletedLow Back Pain | SciaticaPalestinian Territory, occupied
-
Tung Yu-ChingChang Gung Memorial HospitalCompleted
-
University Hospital, AntwerpCompletedThe Influence of Posture on Airway Diameter, Resistance and Airflow Distribution in Healthy SubjectsHealthy ParticipantsBelgium
-
Military Institute of Medicine, PolandCompleted
-
Novartis PharmaceuticalsCompletedCardiovascular Disease and Lipoprotein(a)China, Germany, United States, Colombia, South Africa, Italy, Spain, Belgium, Egypt, Hungary, Taiwan, Turkey, Japan, Netherlands, Australia, Austria, Canada, Czechia, France, Israel, Switzerland, United Kingdom, Korea, Republic of, Th... and more
-
Anna OlczakCompletedStroke, IschemicPoland
-
Hopital FochCompletedPostoperative Oxygen TherapyFrance
-
Anna OlczakCompleted